Search Results for keywords:"regulatory review"

The Agricultural Marketing Service of the USDA announced a delay in the effective date of a rule regarding the Paper and Paper-Based Packaging Promotion, Research, and Information Order. Originally set to take effect on January 21, 2025, the rule is now postponed until March 21, 2025. This delay allows for further review of the amendments, which clarify various processes like partnership definitions, nomination procedures, and voting formats for board meetings, along with financial reporting timelines. The postponement aligns with a presidential directive for regulatory review.

The Department of Agriculture is requesting public comments on an information collection related to the Supplemental Nutrition Assistance Program (SNAP) and disaster relief food distribution. This request is part of a review by the Office of Management and Budget, as required by the Paperwork Reduction Act. People are invited to comment on whether the information collection is necessary and how it could be improved. Comments should be submitted by March 22, 2021, through the website www.reginfo.gov.

The Centers for Medicare & Medicaid Services from the Department of Health and Human Services is delaying the effective date of a new rule concerning Medicare Part D. Originally set to take effect on February 1, 2021, the rule will now start on March 30, 2021. This delay follows a Presidential memorandum on January 20, 2021, aiming to freeze new regulations for 60 days. The rule in question will establish a new electronic standard for how prescribers and insurers manage authorizations for prescription drugs under Medicare Part D.

The Department of the Interior and the Department of the Army have decided to delay the effective date of a rule related to reservoir project lands. This decision is in line with a directive from President Trump's administration to pause new regulations for review. Initially set to take effect on April 16, 2025, the rule's implementation is postponed to May 16, 2025. The delay allows further evaluation and is made without public comments, as it aims to ensure regulations are carefully considered.

The Department of Housing and Urban Development (HUD) has announced a delay in the effective date of new construction and safety standards for manufactured homes. Initially set to take effect on March 17, 2025, the new date is now September 15, 2025. This adjustment aligns with a Presidential order for a regulatory review period and responds to manufacturers' requests for more time to adjust to new regulations. The delay aims to ensure all changes are properly reviewed and implemented for better housing safety and quality.

The Federal Motor Carrier Safety Administration (FMCSA) announced it will not enforce a rule titled "Federal Motor Carrier Safety Regulations; Correction" until March 20, 2025. This decision was made to allow time for a review of the rule by executive departments and agencies, ensuring it aligns with legal and policy requirements. The rule, originally published on January 10, 2025, corrected two errors in a previous regulation. FMCSA's action is part of a broader regulatory review initiated by the President.

The Western Pacific Fishery Management Council is organizing several public meetings to address fishery management issues in the Western Pacific Region. These meetings, taking place in late February and early March 2025, involve different advisory panels and committees focusing on the Mariana Archipelago with specific meetings for the Commonwealth of the Northern Mariana Islands (CNMI) and Guam. Attendees can participate either in person or remotely via Webex. The meetings will include discussions on strategic planning, regulatory reviews, community consultations, and the impact of climate change on fisheries. Public comment periods will be incorporated into the agenda.

On January 7, 2021, the U.S. Fish and Wildlife Service published a final rule concerning the Migratory Bird Treaty Act (MBTA) which aimed to exclude incidental take of migratory birds from prohibited activities. However, the rule's effective date, initially set for February 8, 2021, has been delayed to March 8, 2021. This decision follows the Congressional Review Act, ongoing litigation, and concerns from the Canadian government. The delay allows for further review and public comment on whether the rule should be amended, further delayed, or rescinded entirely.

The United States Patent and Trademark Office has granted a one-year interim extension for U.S. Patent No. 6,953,476, which belongs to Neovasc Medical Ltd. This patent covers an implantable device called Reducer®, and the extension was needed because the regulatory review by the Food and Drug Administration is expected to take longer than the patent's original expiration date. The extension allows Neovasc more time to prepare while waiting for the FDA's approval process to conclude.

The United States Patent and Trademark Office (USPTO) has granted a one-year interim extension for U.S. Patent No. 7,534,790, which covers the drug vernakalant hydrochloride. The extension was necessary because the regulatory review by the Food and Drug Administration (FDA) will extend beyond the patent's expiration date of March 31, 2021. Correvio International Sàrl, the patent owner, applied for this third interim extension as allowed under U.S. patent law for certain cases where market approval is pending. This extension ensures the patent remains valid while the review process continues.